Andrew I. Koven, President & Chief Business Officer at Aralez Pharmaceuticals Inc. (ARLZ), sold 13,964 shares at $0.52 ($7K) on 2018-05-14, disclosed to the SEC on 2018-05-16.
Scheduled sale ($7k) by President & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARLZ | SELL | 2017-06-06 | $414K | — | Filing → |
| ARLZ | SELL | 2017-03-22 | $19K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $51K | — | Filing → |